SMAD4 and colorectal carcinoma: Recent evidence further underscores the biological significance of these alterations in distinguishing aggressive CRC phenotypes, noting that the absence of SMAD4 variants is a hallmark of patients who maintain indolent, organ‐limited disease [38].